To understand the role of AIM2 in defense against systemic candidiasis, we sourced bulk RNA-seq data from peripheral blood mononuclear cells (PBMCs) or monocyte-derived dendritic cells of healthy volunteers challenged ex vivo with C. albicans (GSE69723, GSE42606, GSE162746) [38–40]. This evidence concerns the gene AIM2 and candidiasis.